Why Sorrento Therapeutics Inc?
* I'm personally invested in this company, so I'm sharing my strategy and possible we can agree or disagree on my outlook for this stock.
*Stats (Positive) 52 Week Price Performance at a decent 51.3% 90 Day Avg Volume 3.6 M (awesome for its current price performance momentum)
with a target price range for the next 12 months between $18 to 24$ per share.
(Negative) Missed last three Quarters EPS goal. EPS Growth (TTM vs prior TTM) -143.01% 1 Year Annualized Beta 1.43 (No bueno!)
*The following two drugs have been or will soon be submitted to the NDA for approval (phase trials are completed)
-ZTlido™ (lidocaine topical system) 1.8% relief of pain associated with PHN
As stated in my prior idea, I'm not a professional investor therefore I'm not providing financial or trading advice. I'm sharing an idea, so I can socialized with other traders and investors for suggestions, guidance, and advice to grow my knowledge.
Thank you for taking the time to read! Have a great trading day!NASDAQ:SRNE
Sources: access the SRNE site for cited sources relating to the drugs being developed.
* I'm personally invested in this company, so I'm sharing my strategy and possible we can agree or disagree on my outlook for this stock.
*Stats (Positive) 52 Week Price Performance at a decent 51.3% 90 Day Avg Volume 3.6 M (awesome for its current price performance momentum)
with a target price range for the next 12 months between $18 to 24$ per share.
(Negative) Missed last three Quarters EPS goal. EPS Growth (TTM vs prior TTM) -143.01% 1 Year Annualized Beta 1.43 (No bueno!)
*The following two drugs have been or will soon be submitted to the NDA for approval (phase trials are completed)
-ZTlido™ (lidocaine topical system) 1.8% relief of pain associated with PHN
As stated in my prior idea, I'm not a professional investor therefore I'm not providing financial or trading advice. I'm sharing an idea, so I can socialized with other traders and investors for suggestions, guidance, and advice to grow my knowledge.
Thank you for taking the time to read! Have a great trading day!NASDAQ:SRNE
Sources: access the SRNE site for cited sources relating to the drugs being developed.